Company Information & Drug Savings for CV Therapeutics, Inc. Medications

CV Therapeutics, acquired by Gilead Sciences, was a pharmaceutical company focused on cardiovascular medicines. The company developed Ranexa (ranolazine) for chronic angina and Lexiscan (regadenoson) for cardiac stress testing. Gilead continues marketing these cardiovascular products while advancing heart disease research.